Does ATOGEPANT Cause Therapeutic product effect incomplete? 125 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 125 reports of Therapeutic product effect incomplete have been filed in association with ATOGEPANT (Qulipta). This represents 2.8% of all adverse event reports for ATOGEPANT.
125
Reports of Therapeutic product effect incomplete with ATOGEPANT
2.8%
of all ATOGEPANT reports
0
Deaths
4
Hospitalizations
How Dangerous Is Therapeutic product effect incomplete From ATOGEPANT?
Of the 125 reports, 4 (3.2%) required hospitalization.
Is Therapeutic product effect incomplete Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ATOGEPANT. However, 125 reports have been filed with the FAERS database.
What Other Side Effects Does ATOGEPANT Cause?
Migraine (908)
Drug ineffective (581)
Headache (497)
Nausea (453)
Constipation (376)
Fatigue (282)
Dizziness (192)
Therapy interrupted (175)
Decreased appetite (127)
Vomiting (108)
What Other Drugs Cause Therapeutic product effect incomplete?
ALBUTEROL (8,496)
ADALIMUMAB (6,986)
PREDNISONE (6,709)
METHOTREXATE (6,037)
TOFACITINIB (4,914)
SECUKINUMAB (4,661)
BUDESONIDE\FORMOTEROL (4,392)
TIOTROPIUM (4,327)
MEPOLIZUMAB (4,106)
ETANERCEPT (3,961)
Which ATOGEPANT Alternatives Have Lower Therapeutic product effect incomplete Risk?
ATOGEPANT vs ATOMOXETINE
ATOGEPANT vs ATOMOXETINE\ATOMOXETINE
ATOGEPANT vs ATORVASTATIN
ATOGEPANT vs ATORVASTATIN\EZETIMIBE
ATOGEPANT vs ATOSIBAN